DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ARMY MED RES ACQ ACTIVITY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT9425-23-S-BAA1

NAICS

-

Classification Code

-

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Defense, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), has issued a Broad Agency Announcement (BAA) under procurement identifier HT9425-23-S-BAA1, inviting extramural research and development proposals in support of the U.S. Army Medical Research and Development Command’s (USAMRDC) mission. This BAA, active from October 1, 2022, through September 30, 2027, seeks to advance medical science and technology solutions that address critical health challenges faced by American Service Members both domestically and abroad, with the added intent to benefit the broader public. The scope of this BAA encompasses basic and applied research, as well as advanced technology development and, under certain conditions, advanced component development and prototypes. The focus is on scientific study and experimentation aimed at advancing the state-of-the-art or increasing knowledge and understanding, rather than the development of specific systems or hardware solutions. Research funded through this opportunity is expected to inform and enhance both military and civilian medical practices and knowledge bases. This BAA is issued under the authority of 10 USC 4001 and in accordance with the Competition in Contracting Act of 1984, as implemented in FAR 6.102(d)(2), FAR 35.016, and DoDGARs 22.315. The competitive selection process is rigorous, with the volume of high-quality submissions typically exceeding available funding. Proposals are evaluated based on criteria outlined in the BAA, which also details research areas of interest, submission instructions, and administrative requirements. Interested parties must first submit a pre-proposal or pre-application via the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org/. Pre-proposals may be submitted at any time during the five-year open period. Only those whose pre-proposals are of interest to USAMRDC will be invited to submit a full proposal or application, which must then be submitted through Grants.gov. The BAA and accompanying “General Submission Instructions” are available on Grants.gov, providing comprehensive guidance for applicants. The contracting entity for this opportunity is the Army Medical Research Acquisition Activity, a federal office under the Department of the Army. The BAA is classified as a Special Notice and is currently active, with a final response date of January 10, 2027. Additional details and updates can be accessed via the official SAM.gov opportunity page at https://sam.gov/opp/e7b1cc12d9d644c291c9f2c1fbb194f2/view. This opportunity is particularly suited for organizations and investigators engaged in innovative medical research and development, with the capacity to contribute to the advancement of military and civilian healthcare. Contractors should carefully review the BAA and associated instructions to ensure alignment with their capabilities and research interests, and to understand the submission and evaluation process.